Michael Fenwick

Michael Fenwick serves as a key partner at Bereskin & Parr LLP, where he significantly contributes to the Life Sciences group and spearheads the Psychedelic practice group. Specializing in the realm of chemistry, his expertise encompasses a wide array of sectors including pharmaceuticals, industrial chemicals, cannabis, and the burgeoning field of psychedelics. Michael is adept at guiding both burgeoning startups and established corporations, along with academic institutions, through the intricate process of developing and managing their intellectual property portfolios. He is proficient in crafting and prosecuting chemical patent applications, providing insightful analyses on patent validity, and offering strategic advice on infringement and operational freedom within the chemical patent domain. Michael is also a recognized figure in the chemical and pharmaceutical patent community, often sharing his expertise and latest findings at specialized conferences, particularly those focusing on psychedelic innovations.

Beyond his professional endeavors, Michael dedicates his time to his three sports-enthusiastic sons, frequently transporting them to various sporting events and coaching their baseball teams. In his scarce free moments, he enjoys following the Toronto Blue Jays.

Michael's academic background is as impressive as his professional achievements, holding an LL.B. from Osgoode Hall Law School, an M.Sc. in Organic Chemistry, and a B.Sc. in Biology, all from the University of Toronto. His professional credentials are comprehensive, with registrations as a patent agent in both the United States and Canada, and his admission to the Ontario Bar.

Michael's active involvement in notable organizations such as the Association of University Technology Managers and the Intellectual Property Institute of Canada illustrates his commitment to the intellectual property field.

His areas of expertise are extensive, covering chemical AI, life sciences, litigation and contentious IP issues, nanotechnology, oil and gas, patents, and psychedelics, making him an invaluable resource for clients navigating the complex landscape of intellectual property in the chemical and life sciences sectors.